01.03.2009 | Original Research
Baseline characteristics of the Indian cohort from the IMPROVE™ study: a multinational, observational study of biphasic insulin aspart 30 treatment for type 2 diabetes
Erschienen in: Advances in Therapy | Ausgabe 3/2009
Einloggen, um Zugang zu erhalten